• Accelerating TB vaccine Research & Development through partnership
  • TBVI TBVI TBVI
    • Home
    • About us
      • TBVI at a glance
      • Mission
      • Organisation
        • Governance Board
        • Advisory Committee
        • Steering Committee
        • Operational Office
        • Product and Clinical Development Team
        • Portfolio Management Committee
      • TBVI consortium
      • Key achievements and impact
      • Financials
      • Policies
    • What we do
      • Pipeline of vaccines
      • Research & Development
      • Services
    • How we work
      • Business model
      • Partnership
    • For partners
      • For researchers and vaccine developers
        • Partners pages
        • Access to services
      • MTBVAC in Newborns
        • Coordinator and partners
        • News and Publications
        • Communication tools
      • MTBVACN3
        • Work packages
        • Governance
        • The consortium and its partners
        • Publications and news
        • Acknowledgement
      • TBVAC2020
        • Word from the chair
        • TBVAC2020 project overview and achievements
        • TBVAC2020 project members
        • TBVAC2020 scientific publications
        • TBVAC2020 other publications
      • For funders
        • TBVI R&D priorities and funding opportunities
        • TBVI service provision and funding opportunities
        • Why invest in TBVI
    • News
    • Contact us:

    Archives

    Monthly Archive for: "January, 2021"
    Home / 2021 / January
      0
    By Marit Holleman
    In Uncategorized Posted January 25, 2021

    HIV & TB: An R&D tale of two vaccines

    27 January IAS (International AIDS Society) and TBVI are co-chairing a virtual satellite ‘HIV & TB: An R&D tale of two vaccines’. This virtual satellite will examine lessons learned from [...]

    Read More
      0
    By Marit Holleman
    In Uncategorized Posted January 20, 2021

    Two publications with promising results about alternative routes of TB vaccine administration

    To fight tuberculosis, better vaccination strategies are needed. Two recent publications demonstrate the positive effects of alternative mucosal routes of administration on the ensuing innate and [...]

    Read More
      0
    By Cora Agterdenbosch
    In Uncategorized Posted January 11, 2021

    Global Roadmap for Research and Development for TB vaccines

    The Amsterdam Institute for Global Health and Development (aighd) is posting the Global Roadmap for R&D for TB vaccines (roadmap) that they have been developing with key stakeholders ( [...]

    Read More
      0
    By Marit Holleman
    In Uncategorized Posted January 5, 2021

    Publication: “MTBVAC vaccination protects rhesus macaques against aerosol challenge with M. tuberculosis and induces immune signatures analogous to those observed in clinical studies”

    Nature published the outcome of a study that demonstrated that a single intradermal vaccination with MTBVAC given to adult rhesus macaques was well tolerated and conferred a significant [...]

    Read More
    Load More
    Menu
    • Home
    • About us
    • What we do
    • How we work
    • For researchers and vaccine developers
    • For funders
    • Pipeline of vaccines
    • News
    TuBerculosis Vaccine Initiative (TBVI)

    Runderweg 6
    8219 PK Lelystad
    The Netherlands
    Email: info@tbvi.eu
    Phone: +31 320 277 550

    © 2015 TuBerculosis Vaccine Initiative (TBVI) | ALL RIGHTS RESERVED | Disclaimer | Sitemap | Door Internetbureau Redkiwi

    Start typing and press Enter to search

    Cookies

    This website uses cookies that help the website function

    OK No